BRL-37344
| BRL-37344 | |
|---|---|
| BRL-37344_structure.png | |
| INN | |
| Drug class | |
| Routes of administration | |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | |
| CAS Number | 99755-59-6 |
| PubChem | 57334 |
| DrugBank | |
| ChemSpider | 51677 |
| KEGG | |
BRL-37344 is an experimental drug that acts as a selective agonist for the beta-3 adrenergic receptor. It has been studied for its potential effects on lipolysis and thermogenesis, which are processes involved in the regulation of body weight and metabolism.
Mechanism of Action[edit]
BRL-37344 primarily targets the beta-3 adrenergic receptor, which is predominantly found in adipose tissue. Activation of this receptor leads to the stimulation of adenylate cyclase, resulting in increased levels of cyclic AMP (cAMP). Elevated cAMP levels activate protein kinase A (PKA), which in turn promotes the breakdown of triglycerides into free fatty acids and glycerol, a process known as lipolysis. Additionally, BRL-37344 enhances thermogenesis by increasing the activity of uncoupling protein 1 (UCP1) in brown adipose tissue.
Potential Applications[edit]
Research on BRL-37344 has explored its potential use in the treatment of obesity and type 2 diabetes. By promoting lipolysis and thermogenesis, BRL-37344 may help in reducing body fat and improving insulin sensitivity. However, further studies are needed to fully understand its efficacy and safety in humans.
Related Compounds[edit]
BRL-37344 is part of a class of compounds known as beta-3 adrenergic receptor agonists. Other related compounds include:
See Also[edit]
References[edit]
 | This medical article is a stub. You can help WikiMD by expanding the page. |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
